There is a dramatic change taking place in market leadership. This has caused great turnover in market momentum…and thus great turnover in the POWR Ratings.

I shared the positive view of that story yesterday when I highlighted: 101 Fresh Upgrades to Start the Week. But today we have to look at the flip side of the coin, and why a blue chip like Biogen (BIIB) finds themselves as Sell rated stocks. In all there are 66 new stocks that tumbled to D (Sell) and F (Strong Sell) ratings.

One Word of Caution

A lot of the stocks on this list are in the energy group because that industry was under pressure til today when the events in Saudi Arabia led to a 15% in oil prices. That is obviously a new positive for energy shares. So I would expect those stocks to quickly rise in our ratings model.

The other stocks on this list don’t have such a convenient excuse. Back to Biogen, for example, there is just nothing going right for the stock. It fell off a cliff back in late March and is down 21% on the year.

What’s even worse is that it is down that same 21% going back 5 years. This is just a stock with no positive traction in place…and likely not going to find that upside catalyst any time soon.

The point is simple, if you have any non-energy shares on this Sell list below…then you should consider removing them from your portfolio as odds point to continued underperformance ahead.

Also consider getting full access to the POWR Ratings so you have a daily update of the stocks with the most upside potential to add to your portfolio. And those poor unfortunate souls like the 66 companies below that should be cut from your holdings.

Gladly we now have a 30 day free trial available for POWR Ratings Premium so you can appreciate all the rest of the resources that can help you stay a step ahead of the market.

About 30 Day Free Trial

To discover more about the attractiveness…or in this case “unattractiveness” of each stock, just click on their ticker to go to our quote pages. Once there you can see the 4 components of the POWR Rating to appreciate how it truly stacks up. (Buy & Hold Grade, Trade Grade, Industry Rank, and Peer Grade).

BIIB shares were trading at $235.95 per share on Monday afternoon, down $0.68 (-0.29%). Year-to-date, BIIB has declined -21.59%, versus a 21.25% rise in the benchmark S&P 500 index during the same period.

More Resources for the Stocks in this Article